These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34107233)

  • 1. A conceptual approach to the rationale for SARS-CoV-2 vaccine allocation prioritisation.
    Kohns Vasconcelos M; Marazia C; Koniordou M; Fangerau H; Drexler I; Afum-Adjei Awuah A
    Pathog Glob Health; 2021 Jul; 115(5):273-276. PubMed ID: 34107233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Justice in COVID-19 vaccine prioritisation: rethinking the approach.
    Rhodes R
    J Med Ethics; 2021 Sep; 47(9):623-631. PubMed ID: 34108257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.
    Hughes K; Gogineni V; Lewis C; Deshpande A
    Curr Med Res Opin; 2021 Jun; 37(6):907-909. PubMed ID: 33760673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
    Hogan AB; Winskill P; Watson OJ; Walker PGT; Whittaker C; Baguelin M; Brazeau NF; Charles GD; Gaythorpe KAM; Hamlet A; Knock E; Laydon DJ; Lees JA; Løchen A; Verity R; Whittles LK; Muhib F; Hauck K; Ferguson NM; Ghani AC
    Vaccine; 2021 May; 39(22):2995-3006. PubMed ID: 33933313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study.
    Wang W; Wu Q; Yang J; Dong K; Chen X; Bai X; Chen X; Chen Z; Viboud C; Ajelli M; Yu H
    BMJ; 2020 Dec; 371():m4704. PubMed ID: 33323388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination as an Equaliser? Evaluating COVID-19 Vaccine Prioritisation and Compensation.
    Günther C; Tonti L; Domenici I
    Med Law Rev; 2022 Dec; 30(4):584-609. PubMed ID: 36482837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review.
    Saadi N; Chi YL; Ghosh S; Eggo RM; McCarthy CV; Quaife M; Dawa J; Jit M; Vassall A
    BMC Med; 2021 Dec; 19(1):318. PubMed ID: 34847950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why should HCWs receive priority access to vaccines in a pandemic?
    Symons X; Matthews S; Tobin B
    BMC Med Ethics; 2021 Jun; 22(1):79. PubMed ID: 34176474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
    Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
    Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
    [No Abstract]   [Full Text] [Related]  

  • 13. Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources.
    Leclerc T; Donat N; Donat A; Pasquier P; Libert N; Schaeffer E; D'Aranda E; Cotte J; Fontaine B; Perrigault PF; Michel F; Muller L; Meaudre E; Veber B
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):333-339. PubMed ID: 32426441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intersectional human rights approach to prioritising access to COVID-19 vaccines.
    Sekalala S; Perehudoff K; Parker M; Forman L; Rawson B; Smith M
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33627362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine.
    Kirwin E; Rafferty E; Harback K; Round J; McCabe C
    Pharmacoeconomics; 2021 Sep; 39(9):1059-1073. PubMed ID: 34138458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region.
    Liu Y; Sandmann FG; Barnard RC; Pearson CAB; ; Pastore R; Pebody R; Flasche S; Jit M
    medRxiv; 2021 Jul; ():. PubMed ID: 34282421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ethical perspective for the COVID-19 vaccine prioritization in Chile].
    García C; Luco L; Gómez MI; Martínez C
    Rev Med Chil; 2021 Dec; 149(12):1795-1800. PubMed ID: 35735347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical Considerations in Vaccine Allocation.
    Reis-Dennis S; Applewhite MK
    Immunol Invest; 2021 Oct; 50(7):857-867. PubMed ID: 34036865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing the public for COVID-19 vaccines: How can general practitioners build vaccine confidence and optimise uptake for themselves and their patients?
    Danchin M; Biezen R; Manski-Nankervis JA; Kaufman J; Leask J
    Aust J Gen Pract; 2020 Oct; 49(10):625-629. PubMed ID: 33015676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.